Calls Now Open

2024 ADDF-Harrington + 2025 Harrington Scholar-Innovator Programs

You've just added:

Our Impact

How we're advancing cures globally

188

Medicines in the making

66

Institutions supported

39

Companies launched

21

Medicines in the clinic

15

Licenses to pharma

What sets us apart

In addition to receiving funding, every scholar is paired with a results-oriented and mission-focused team from our Therapeutics Development Center. Teams consist of a project manager and experienced pharma and business development advisors with a track record of bringing new drugs to market.

Learn More

Making discoveries partner-ready

Our pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.

See all discoveries

Accelerating Scientific Breakthroughs

Our pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.

See all discoveries

The Latest

See All News
Harrington Discovery Institute Opens Call for 2025 Harrington Scholar-Innovator Award

Press Releases

Harrington Discovery Institute Opens Call for 2025 Harrington Scholar-Innovator Award

Unique program for physician-scientists to advance promising discoveries into medicines

Continue Reading
Harrington Discovery Institute Announces 2024 Scholar-Innovator Award Recipients

Press Releases

Harrington Discovery Institute Announces 2024 Scholar-Innovator Award Recipients

10 physician-scientists have been selected for drug development grant to advance discoveries into the clinic

Continue Reading
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.